Sleep apnea

Introducing the AirFit F40: Experience Unprecedented Freedom with the Comfort and Optimized Seal Performance of ResMed’s Smallest Full-Face CPAP Mask

Retrieved on: 
Wednesday, March 6, 2024

Featuring the AdaptiSeal™ cushion made of 100% soft silicone to adapt to various facial contours, allowing for a secure and comfortable seal throughout the night.

Key Points: 
  • Featuring the AdaptiSeal™ cushion made of 100% soft silicone to adapt to various facial contours, allowing for a secure and comfortable seal throughout the night.
  • The AirFit F40 addresses this problem by providing the necessary pressure support in a more comfortable, lower-profile full-face mask.
  • The mask is ideal for people who sleep on their side, are claustrophobic, and want the stability and seal of a universal fit mask in a minimalist design.
  • AirFit F40 masks are available in the U.S., with plans to launch in Canada, followed by EMEA, Latin America, and APAC.

ProSomnus Reports Successful Pilot Study Validation of Next Generation Remote Patient Monitoring Device for Obstructive Sleep Apnea

Retrieved on: 
Thursday, February 22, 2024

PLEASANTON, Calif., Feb. 22, 2024 (GLOBE NEWSWIRE) -- ProSomnus, Inc. (NASDAQ: OSA ) (the “Company”), the leading non-CPAP Obstructive Sleep Apnea (OSA) therapy™, announced results of its pilot study for the Company’s Next Generation Remote Patient Monitoring (RPM) device for Obstructive Sleep Apnea (OSA).

Key Points: 
  • PLEASANTON, Calif., Feb. 22, 2024 (GLOBE NEWSWIRE) -- ProSomnus, Inc. (NASDAQ: OSA ) (the “Company”), the leading non-CPAP Obstructive Sleep Apnea (OSA) therapy™, announced results of its pilot study for the Company’s Next Generation Remote Patient Monitoring (RPM) device for Obstructive Sleep Apnea (OSA).
  • “This pilot study validation represents a step toward bringing sleep medicine into the P4 medicine era.
  • The ProSomnus® RPMO2 OSA Device enables sleep medicine to be more personalized, predictive, preventative, and participatory,” commented Len Liptak, Chief Executive Officer for ProSomnus Sleep Technologies.
  • “The results of the pilot testing hold tremendous promise for the formal validation testing, in which the ProSomnus RPMO2 OSA Device will be compared against a gold standard.”

Signifier Medical Technologies Announces Publication of a New Study Exploring Cost-Effectiveness of Neuromuscular Electrical Stimulation for the Treatment of Mild Obstructive Sleep Apnea

Retrieved on: 
Thursday, March 7, 2024

Signifier Medical Technologies LLC (“Signifier” or the “Company”), a Boston-based medical technology company, announces that The International Journal of Technology Assessment in Health Care has recently published an exploratory analysis entitled " Cost-Effectiveness of Neuromuscular Electrical Stimulation for the Treatment of Mild Obstructive Sleep Apnea ."

Key Points: 
  • Signifier Medical Technologies LLC (“Signifier” or the “Company”), a Boston-based medical technology company, announces that The International Journal of Technology Assessment in Health Care has recently published an exploratory analysis entitled " Cost-Effectiveness of Neuromuscular Electrical Stimulation for the Treatment of Mild Obstructive Sleep Apnea ."
  • Shan Liu, Jan Pietzsch, and a collaborative research team explores the cost-effectiveness of using neuromuscular electrical stimulation (NMES) as a treatment option for patients with mild obstructive sleep apnea (OSA).
  • The results of the exploratory analysis indicated that neuromuscular electrical stimulation may be a cost-effective treatment option for mild OSA compared to no treatment.
  • "We are excited to see the results of this study reinforce the potential of neuromuscular electrical stimulation as a revolutionary treatment option for individuals with mild obstructive sleep apnea," states Mujtaba Chohan, Head of Finance & Chief of Staff at Signifier.

Allegheny Health Network Launches New Program for the Treatment of Insomnia

Retrieved on: 
Tuesday, March 5, 2024

PITTSBURGH, March 5, 2024 /PRNewswire-PRWeb/ -- Allegheny Health Network (AHN) today announced that it has launched a new, evidence-based treatment program to help patients with insomnia improve their sleep quality and quantity without the use of medication. Supported by grant funding from the Richard King Mellon Foundation, the Cognitive Behavioral Therapy for Insomnia (CBTI) program at AHN is a blended effort between the AHN Primary Care Institute, AHN Psychiatry & Behavioral Health Institute and Highmark Health.

Key Points: 
  • PITTSBURGH, March 5, 2024 /PRNewswire-PRWeb/ -- Allegheny Health Network (AHN) today announced that it has launched a new, evidence-based treatment program to help patients with insomnia improve their sleep quality and quantity without the use of medication.
  • Supported by grant funding from the Richard King Mellon Foundation, the Cognitive Behavioral Therapy for Insomnia (CBTI) program at AHN is a blended effort between the AHN Primary Care Institute, AHN Psychiatry & Behavioral Health Institute and Highmark Health.
  • Patients may access the AHN CBTI program via the AHN Primary Care Institute, AHN Psychiatry & Behavioral Health Institute or the AHN Medicine Institute.
  • "Adding CBTI as a whole-person approach to care at AHN is another important step to reinventing health with our Living Health strategy."

360 Dental Lounge Grand Opening in Mansfield

Retrieved on: 
Tuesday, March 5, 2024

MANSFIELD, Texas, March 5, 2024 /PRNewswire/ -- On March 16, 2024, a brand-new dental practice named 360 Dental Lounge will open on Broad Street in Mansfield, TX. It is locally owned and operated by a husband-and-wife team, Dr. Rushabh Doshi and Dr. Rini Bavishi, who have more than 30 years of combined expertise and experience. After practicing in Irving and Las Colinas, they are excited to become part of and serve the Mansfield community.

Key Points: 
  • MANSFIELD, Texas, March 5, 2024 /PRNewswire/ -- On March 16, 2024, a brand-new dental practice named 360 Dental Lounge will open on Broad Street in Mansfield, TX.
  • After practicing in Irving and Las Colinas, they are excited to become part of and serve the Mansfield community.
  • Ranging from simple dental checkups and cleanings to complex dental implants and other procedures, they have the expertise necessary to meet each patient's unique needs, including specialty services.
  • In the practice, Dr. Bavishi and Dr. Doshi take advantage of the most cutting-edge technology and services available including the following to improve the dental experience and provide these advanced dental procedures:

Sleep Apnea Symptoms Linked to Memory and Thinking Problems

Retrieved on: 
Monday, March 4, 2024

"Our study found participants who had sleep apnea symptoms had greater odds of having memory or thinking problems."

Key Points: 
  • "Our study found participants who had sleep apnea symptoms had greater odds of having memory or thinking problems."
  • Of those with symptoms, 357 people, or 33%, reported memory or thinking problems compared to 628 people, or 20% of people without sleep apnea symptoms.
  • After adjusting for other factors that could affect memory and thinking problems, such as age, race, gender and education, researchers found that people who reported sleep apnea symptoms were about 50% more likely to also report having memory or thinking problems compared to people who did not have sleep apnea symptoms.
  • Additional studies are needed following people's sleep apnea, memory and thinking symptoms over time.

Sleep Center of Littleton Introduces an Alternative to CPAP Therapy

Retrieved on: 
Wednesday, February 28, 2024

LITTLETON, Colo., Feb. 28, 2024 /PRNewswire/ -- Sleep Center of Littleton, a leading provider of sleep apnea treatment, is excited to announce the introduction of an innovative alternative to Continuous Positive Airway Pressure (CPAP) therapy.

Key Points: 
  • LITTLETON, Colo., Feb. 28, 2024 /PRNewswire/ -- Sleep Center of Littleton, a leading provider of sleep apnea treatment, is excited to announce the introduction of an innovative alternative to Continuous Positive Airway Pressure (CPAP) therapy.
  • Recognizing these challenges, Sleep Center of Littleton is now offering an excellent alternative: oral appliance therapy.
  • "The introduction of oral appliance therapy is a game-changer for individuals who have struggled with CPAP therapy," said Dr. Thomas R. Froning, a Qualified Sleep Dentist and founder of Sleep Center of Littleton.
  • For individuals who have struggled with CPAP therapy or are searching for an effective alternative, Sleep Center of Littleton offers a ray of hope.

Latest EnsoData FDA 510(k) Clearance Enables AI-Powered Sleep Diagnosis Using Pulse Oximetry Devices

Retrieved on: 
Monday, February 26, 2024

MADISON, Wis., Feb. 26, 2024 /PRNewswire/ -- EnsoData, a pioneer in healthcare AI, achieved FDA 510(k) clearance for groundbreaking technology that enables AI-powered sleep diagnosis using FDA-cleared pulse oximetry (pulse ox) devices. Powered by EnsoSleep PPG scoring, widely available and wearable pulse ox technology can be deployed for a high quality, accessible, and cost-effective approach to diagnosing sleep disorders, including sleep apnea.

Key Points: 
  • New EnsoData Diagnostic AI Advances Mission to Make Healthcare More Accessible, Affordable for Patients
    MADISON, Wis., Feb. 26, 2024 /PRNewswire/ -- EnsoData , a pioneer in healthcare AI, achieved FDA 510(k) clearance for groundbreaking technology that enables AI-powered sleep diagnosis using FDA-cleared pulse oximetry (pulse ox) devices.
  • "Expanding EnsoData's capability to collect and analyze PPG signals from simple, wearable pulse ox devices will accelerate the identification, diagnosis and treatment of sleep disordered breathing events, including sleep apnea," said Justin Mortara, President and CEO of EnsoData.
  • Compared to earlier generations of sleep diagnostic equipment, pulse ox devices are smaller and less expensive.
  • "This FDA clearance marks a pivotal moment in sleep diagnostics, and also long-term therapy monitoring and management, where enhanced accessibility and affordability can create a new normal in sleep care."

Health E-Commerce® partners with Lofta, making CPAP devices available on FSA Store® and HSA Store®

Retrieved on: 
Tuesday, February 13, 2024

DALLAS, Feb. 13, 2024 /PRNewswire-PRWeb/ -- It's estimated that more than 30 million people in the United States have sleep apnea and 33 million use a CPAP machine to manage this condition. Untreated, sleep apnea can contribute to a number of serious health conditions, including heart disease, memory loss, depression, and headaches. However, thanks to a new partnership between Health-E Commerce® and Lofta, individuals with sleep apnea can now purchase Lofta sleep apnea devices with tax-free flexible spending account (FSA) or health savings account (HSA) funds at FSA Store® and HSA Store®.

Key Points: 
  • Untreated, sleep apnea can contribute to a number of serious health conditions, including heart disease, memory loss, depression, and headaches.
  • However, thanks to a new partnership between Health-E Commerce® and Lofta , individuals with sleep apnea can now purchase Lofta sleep apnea devices with tax-free flexible spending account (FSA) or health savings account (HSA) funds at FSA Store® and HSA Store® .
  • We're immensely proud of our new partnership with Lofta, which allows FSA Store and HSA Store to meet the changing needs of account holders, improve chronic condition management, and support whole-person health.
  • The Lofta team believes this partnership with Health E-Commerce will advance their mission to bring good sleep to those who need it.

Edgepark adding first-of-its kind, fully automated insulin delivery system to diabetes portfolio

Retrieved on: 
Tuesday, February 13, 2024

TWINSBURG, Ohio, Feb. 13, 2024 /PRNewswire/ -- Edgepark announced today it is offering the newly launched Beta Bionics iLet Bionic Pancreas fully automated insulin delivery (AID) system as part of its comprehensive diabetes management solution portfolio. The iLet is the first and only system that does not require carbohydrate counting* and fully automates 100 percent of insulin doses. Designed for anyone six years of age and older living with Type 1 diabetes, it eliminates the traditional manual work previously involved with using an insulin pump.

Key Points: 
  • TWINSBURG, Ohio, Feb. 13, 2024 /PRNewswire/ -- Edgepark announced today it is offering the newly launched Beta Bionics iLet Bionic Pancreas fully automated insulin delivery (AID) system as part of its comprehensive diabetes management solution portfolio.
  • The iLet is the first and only system that does not require carbohydrate counting* and fully automates 100 percent of insulin doses.
  • "Edgepark is thrilled to offer the iLet as a first-of-its-kind device that uses automation to make diabetes simpler to navigate."
  • As with any insulin delivery system, users must also be able to load the insulin pump with insulin, insert an infusion set and troubleshoot when challenges occur.